These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31042750)

  • 1. Glibenclamide, a Sur1-Trpm4 antagonist, does not improve outcome after collagenase-induced intracerebral hemorrhage.
    Wilkinson CM; Brar PS; Balay CJ; Colbourne F
    PLoS One; 2019; 14(5):e0215952. PubMed ID: 31042750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glibenclamide does not improve outcome following severe collagenase-induced intracerebral hemorrhage in rats.
    Kung TFC; Wilkinson CM; Dirks CA; Jickling GC; Colbourne F
    PLoS One; 2021; 16(6):e0252584. PubMed ID: 34081746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Glibenclamide in Brain Injury After Intracerebral Hemorrhage.
    Jiang B; Li L; Chen Q; Tao Y; Yang L; Zhang B; Zhang JH; Feng H; Chen Z; Tang J; Zhu G
    Transl Stroke Res; 2017 Apr; 8(2):183-193. PubMed ID: 27807801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glimepiride and glibenclamide have comparable efficacy in treating acute ischemic stroke in mice.
    Wang X; Chang Y; He Y; Lyu C; Li H; Zhu J; Liu K; Hu Y; Huang K; Pan S
    Neuropharmacology; 2020 Jan; 162():107845. PubMed ID: 31704276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glibenclamide ameliorates cerebral edema and improves outcomes in a rat model of status epilepticus.
    Lin Z; Huang H; Gu Y; Huang K; Hu Y; Ji Z; Wu Y; Wang S; Yang T; Pan S
    Neuropharmacology; 2017 Jul; 121():1-11. PubMed ID: 28412320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date.
    King ZA; Sheth KN; Kimberly WT; Simard JM
    Drug Des Devel Ther; 2018; 12():2539-2552. PubMed ID: 30147301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glibenclamide ameliorates the disrupted blood-brain barrier in experimental intracerebral hemorrhage by inhibiting the activation of NLRP3 inflammasome.
    Xu F; Shen G; Su Z; He Z; Yuan L
    Brain Behav; 2019 Apr; 9(4):e01254. PubMed ID: 30859754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage.
    Tosun C; Kurland DB; Mehta R; Castellani RJ; deJong JL; Kwon MS; Woo SK; Gerzanich V; Simard JM
    Stroke; 2013 Dec; 44(12):3522-8. PubMed ID: 24114458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUR1-TRPM4 channels, not K
    Woo SK; Tsymbalyuk N; Tsymbalyuk O; Ivanova S; Gerzanich V; Simard JM
    Neurosci Lett; 2020 Jan; 718():134729. PubMed ID: 31899311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.
    Makar TK; Gerzanich V; Nimmagadda VK; Jain R; Lam K; Mubariz F; Trisler D; Ivanova S; Woo SK; Kwon MS; Bryan J; Bever CT; Simard JM
    J Neuroinflammation; 2015 Nov; 12():210. PubMed ID: 26581714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glibenclamide Directly Prevents Neuroinflammation by Targeting SUR1-TRPM4-Mediated NLRP3 Inflammasome Activation In Microglia.
    He Y; Chang Y; Peng Y; Zhu J; Liu K; Chen J; Wu Y; Ji Z; Lin Z; Wang S; Gupta S; Zang N; Pan S; Huang K
    Mol Neurobiol; 2022 Oct; 59(10):6590-6607. PubMed ID: 35972671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glibenclamide for the treatment of ischemic and hemorrhagic stroke.
    Caffes N; Kurland DB; Gerzanich V; Simard JM
    Int J Mol Sci; 2015 Mar; 16(3):4973-84. PubMed ID: 25749474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Sulfonylurea Receptor 1 and Glibenclamide in Traumatic Brain Injury: A Review of the Evidence.
    Jha RM; Bell J; Citerio G; Hemphill JC; Kimberly WT; Narayan RK; Sahuquillo J; Sheth KN; Simard JM
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of monascin on hematoma clearance and edema after intracerebral hemorrhage in rats.
    Wang J; Wang G; Yi J; Xu Y; Duan S; Li T; Sun XG; Dong L
    Brain Res Bull; 2017 Sep; 134():24-29. PubMed ID: 28655601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfonylurea Receptor 1, Transient Receptor Potential Cation Channel Subfamily M Member 4, and KIR6.2:Role in Hemorrhagic Progression of Contusion.
    Gerzanich V; Stokum JA; Ivanova S; Woo SK; Tsymbalyuk O; Sharma A; Akkentli F; Imran Z; Aarabi B; Sahuquillo J; Simard JM
    J Neurotrauma; 2019 Apr; 36(7):1060-1079. PubMed ID: 30160201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tempol alleviates intracerebral hemorrhage-induced brain injury possibly by attenuating nitrative stress.
    Wanyong Y; Zefeng T; Xiufeng X; Dawei D; Xiaoyan L; Ying Z; Yaogao F
    Neuroreport; 2015 Sep; 26(14):842-9. PubMed ID: 26237245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic benefit of urocortin in rats with intracerebral hemorrhage.
    Liew HK; Hsu CW; Wang MJ; Kuo JS; Li TY; Peng HF; Wang JY; Pang CY
    J Neurosurg; 2012 Jan; 116(1):193-200. PubMed ID: 21981644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death.
    Chu K; Jeong SW; Jung KH; Han SY; Lee ST; Kim M; Roh JK
    J Cereb Blood Flow Metab; 2004 Aug; 24(8):926-33. PubMed ID: 15362723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scutellaria baicalensis attenuates blood-brain barrier disruption after intracerebral hemorrhage in rats.
    Shin JW; Kang HC; Shim J; Sohn NW
    Am J Chin Med; 2012; 40(1):85-96. PubMed ID: 22298450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glibenclamide attenuates brain edema associated with microglia activation after intracerebral hemorrhage.
    Shiokawa R; Otani N; Kajimoto R; Igarashi T; Moro N; Suma T; Oshima H; Yoshino A
    Neurochirurgie; 2022 Dec; 68(6):589-594. PubMed ID: 35963712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.